BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10982834)

  • 21. 2B4 acts as a non-major histocompatibility complex binding inhibitory receptor on mouse natural killer cells.
    Lee KM; McNerney ME; Stepp SE; Mathew PA; Schatzle JD; Bennett M; Kumar V
    J Exp Med; 2004 May; 199(9):1245-54. PubMed ID: 15123744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LILRB4/gp49B Co-Localizes with Integrin via Fibronectin at Focal Adhesion Sites on Mast Cells.
    Miyamoto S; Chiba T; Itoi S; Su MT; Takai T
    Tohoku J Exp Med; 2023 Mar; 259(4):273-284. PubMed ID: 36642505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined natural killer cell and dendritic cell functional deficiency in KARAP/DAP12 loss-of-function mutant mice.
    Tomasello E; Desmoulins PO; Chemin K; Guia S; Cremer H; Ortaldo J; Love P; Kaiserlian D; Vivier E
    Immunity; 2000 Sep; 13(3):355-64. PubMed ID: 11021533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ontogeny and differentiation of murine natural killer cells and their receptors.
    Sivakumar PV; Puzanov I; Williams NS; Bennett M; Kumar V
    Curr Top Microbiol Immunol; 1998; 230():161-90. PubMed ID: 9586356
    [No Abstract]   [Full Text] [Related]  

  • 25. Direct binding of purified HLA class I antigens by soluble NKG2/CD94 C-type lectins from natural killer cells.
    Ding Y; Sumitran S; Holgersson J
    Scand J Immunol; 1999 May; 49(5):459-65. PubMed ID: 10320637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional defects of NK cells treated with chloroquine mimic the lytic defects observed in perforin-deficient mice.
    Austin Taylor M; Bennett M; Kumar V; Schatzle JD
    J Immunol; 2000 Nov; 165(9):5048-53. PubMed ID: 11046034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural killing of MHC class I(-) lymphoblasts by NK cells from long-term bone marrow culture requires effector cell expression of Ly49 receptors.
    Lindberg J; Martín-Fontecha A; Höglund P
    Int Immunol; 1999 Aug; 11(8):1239-46. PubMed ID: 10421781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BST2, a Novel Inhibitory Receptor, Is Involved in NK Cell Cytotoxicity through Its Cytoplasmic Tail Domain.
    Oh J; Yi E; Jeong SK; Park S; Park SH
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutational analysis of the human 2B4 (CD244)/CD48 interaction: Lys68 and Glu70 in the V domain of 2B4 are critical for CD48 binding and functional activation of NK cells.
    Mathew SO; Kumaresan PR; Lee JK; Huynh VT; Mathew PA
    J Immunol; 2005 Jul; 175(2):1005-13. PubMed ID: 16002700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gp49B is a pathogenic marker for auto-antibody-producing plasma cells in lupus-prone BXSB/Yaa mice.
    Wong YL; Su MT; Sugahara-Tobinai A; Itoi S; Kezuka D; Endo S; Inui M; Takai T
    Int Immunol; 2019 May; 31(6):397-406. PubMed ID: 30768140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of the Ly49A gene in murine natural killer cell clones is predominantly but not exclusively mono-allelic.
    Held W; Raulet DH
    Eur J Immunol; 1997 Nov; 27(11):2876-84. PubMed ID: 9394813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transgenic expression of the Ly49A natural killer cell receptor confers class I major histocompatibility complex (MHC)-specific inhibition and prevents bone marrow allograft rejection.
    Held W; Cado D; Raulet DH
    J Exp Med; 1996 Nov; 184(5):2037-41. PubMed ID: 8920892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cloning of the gp49B gene of the immunoglobulin superfamily and demonstration that one of its two products is an early-expressed mast cell surface protein originally described as gp49.
    Castells MC; Wu X; Arm JP; Austen KF; Katz HR
    J Biol Chem; 1994 Mar; 269(11):8393-401. PubMed ID: 8132564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cutting edge: expression of functional CD94/NKG2A inhibitory receptors on fetal NK1.1+Ly-49- cells: a possible mechanism of tolerance during NK cell development.
    Sivakumar PV; Gunturi A; Salcedo M; Schatzle JD; Lai WC; Kurepa Z; Pitcher L; Seaman MS; Lemonnier FA; Bennett M; Forman J; Kumar V
    J Immunol; 1999 Jun; 162(12):6976-80. PubMed ID: 10358137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome.
    Tangye SG; Phillips JH; Lanier LL; Nichols KE
    J Immunol; 2000 Sep; 165(6):2932-6. PubMed ID: 10975798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mouse CD94 participates in Qa-1-mediated self recognition by NK cells and delivers inhibitory signals independent of Ly-49.
    Toyama-Sorimachi N; Taguchi Y; Yagita H; Kitamura F; Kawasaki A; Koyasu S; Karasuyama H
    J Immunol; 2001 Mar; 166(6):3771-9. PubMed ID: 11238619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-4 confers NK stimulatory capacity to murine dendritic cells: a signaling pathway involving KARAP/DAP12-triggering receptor expressed on myeloid cell 2 molecules.
    Terme M; Tomasello E; Maruyama K; Crépineau F; Chaput N; Flament C; Marolleau JP; Angevin E; Wagner EF; Salomon B; Lemonnier FA; Wakasugi H; Colonna M; Vivier E; Zitvogel L
    J Immunol; 2004 May; 172(10):5957-66. PubMed ID: 15128777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NK cell triggering by the human costimulatory molecules CD80 and CD86.
    Wilson JL; Charo J; Martín-Fontecha A; Dellabona P; Casorati G; Chambers BJ; Kiessling R; Bejarano MT; Ljunggren HG
    J Immunol; 1999 Oct; 163(8):4207-12. PubMed ID: 10510357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Virus-Infected Human Mast Cells Enhance Natural Killer Cell Functions.
    Portales-Cervantes L; Haidl ID; Lee PW; Marshall JS
    J Innate Immun; 2017; 9(1):94-108. PubMed ID: 27806369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cumulative inhibition of NK cells and T cells resulting from engagement of multiple inhibitory Ly49 receptors.
    Hanke T; Raulet DH
    J Immunol; 2001 Mar; 166(5):3002-7. PubMed ID: 11207249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.